Keeping psychiatry honest since 2003. News and opinions on mental health from Dr. Carlat, the editorial team, and guest contributors.
Getting Uncomfortable With Esketamine
January 13, 2020
Esketamine (Spravato) was approved in 2019 for treatment resistant depression, but the medicine quickly gathered controversy about its long-term safety. We interview Dr. Nolan Williams from Stanford University about these issues and where esketamine fits in our interventions for treatment resistant depression.